skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Methods for diagnosing bacterial infections

Abstract

The present invention is directed to methods of determining the presence or absence of a bacterial infection in a patient using isotopically-labeled tyrosine and/or isotopically-labeled p-hydroxyphenylacetic acid.

Inventors:
;
Publication Date:
Research Org.:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1459532
Patent Number(s):
10,000,787
Application Number:
14/434,509
Assignee:
STC.UNM (Albuquerque, NM); LOS ALAMOS NATIONAL SECURITY, LLC. (Los Alamos, NM)
DOE Contract Number:  
AC52-06NA25396
Resource Type:
Patent
Resource Relation:
Patent File Date: 2013 Oct 08
Country of Publication:
United States
Language:
English

Citation Formats

Timmins, Graham, and Silks, Louis Pete. Methods for diagnosing bacterial infections. United States: N. p., 2018. Web.
Timmins, Graham, & Silks, Louis Pete. Methods for diagnosing bacterial infections. United States.
Timmins, Graham, and Silks, Louis Pete. Tue . "Methods for diagnosing bacterial infections". United States. https://www.osti.gov/servlets/purl/1459532.
@article{osti_1459532,
title = {Methods for diagnosing bacterial infections},
author = {Timmins, Graham and Silks, Louis Pete},
abstractNote = {The present invention is directed to methods of determining the presence or absence of a bacterial infection in a patient using isotopically-labeled tyrosine and/or isotopically-labeled p-hydroxyphenylacetic acid.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2018},
month = {6}
}

Patent:

Save / Share:

Works referenced in this record:

An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
journal, December 2005

  • McDonald, L. Clifford; Killgore, George E.; Thompson, Angela
  • New England Journal of Medicine, Vol. 353, Issue 23, p. 2433-2441
  • DOI: 10.1056/nejmoa051590

Increase in Adult Clostridium difficile –related Hospitalizations and Case-Fatality Rate, United States, 2000–2005
journal, June 2008

  • Zilberberg, Marya D.; Shorr, Andrew F.; Kollef, Marin H.
  • Emerging Infectious Diseases, Vol. 14, Issue 6, p. 929-931
  • DOI: 10.3201/eid1406.071447

The economic burden of Clostridium difficile
journal, March 2012


Tests for the diagnosis of Clostridium difficile infection: The next generation
journal, August 2011


13[C]-Urea Breath Test as a Novel Point-of-Care Biomarker for Tuberculosis Treatment and Diagnosis
journal, August 2010


The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains
journal, January 2011

  • Dawson, Lisa F.; Donahue, Elizabeth H.; Cartman, Stephen T.
  • BMC Microbiology, Vol. 11, Issue 1, Article No. 86
  • DOI: 10.1186/1471-2180-11-86

Assessing the role of p-cresol tolerance in Clostridium difficile
journal, June 2008

  • Dawson, L. F.; Stabler, R. A.; Wren, B. W.
  • Journal of Medical Microbiology, Vol. 57, Issue 6, p. 745-749
  • DOI: 10.1099/jmm.0.47744-0

Prospective study of Clostridium difficile colonization and para-cresol detection in the stools of babies on a special care unit
journal, August 1984


Water works: an efficient palladium-catalyzed cross-coupling reaction between boronic acids and bromoacetate with aminophosphine ligand
journal, October 2010


Toxicity of Free p-Cresol: A Prospective and Cross-Sectional Analysis
journal, March 2003

  • De Smet, Rita; Van Kaer, Jacqueline; Van Vlem, Bruno
  • Clinical Chemistry, Vol. 49, Issue 3, p. 470-478
  • DOI: 10.1373/49.3.470